- Psoriasis patients have significantly increased risks of depressive disorders, generalized anxiety disorder, PTSD, adjustment disorders, and multiple substance use disorders.
- No significant association was found between psoriasis and bipolar disorder or schizophrenia in propensity matched analysis.
- Findings underscore the need for integrated dermatology and mental health care and for longitudinal studies to clarify causal relationships.
Dermatol Online J. 2026 Aug 31;32(4). doi: 10.25251/j4x8p6bt.
ABSTRACT
BACKGROUND: Psoriasis, a chronic inflammatory skin condition affecting 2%-3% globally, carries a significant psychosocial burden.
OBJECTIVE: To update the psychiatric comorbidity profile in psoriasis patients.
METHODS: Using the TriNetX database, 110,009 psoriasis patients were matched using propensity matching based on age, sex, ethnicity, and race with 110,009 controls. Pre-existing psychiatric conditions were excluded.
RESULTS: Psoriasis patients showed significantly increased risks for depressive episodes, recurrent major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, alcohol-related, opioid-related, cannabis-related, and adjustment disorders. Bipolar disorder and schizophrenia showed no significant association.
CONCLUSION: These findings confirm elevated psychiatric comorbidity in psoriasis. Despite limitations, these findings highlight the critical need for integrated dermatological and mental health care. Longitudinal studies are needed to further explore this association.
PMID:43048785 | DOI:10.25251/j4x8p6bt
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

